Navigation Links
Dynamic Outlines Initial Target Markets for Pharmaceutical Cannabinoid Products
Date:12/5/2008

PALM SPRINGS, Calif., Dec. 5 /PRNewswire-FirstCall/ -- Dynamic Alert Limited (OTC Bulletin Board: DYMC) is pleased to announce that it has now identified its target markets for its pharmaceutical product line-up. The modalities will include a lozenge with some capacity for enhancing rapid onset through oromucosal absorption, topical applications, such as lotions and salves, and various products for internal use. Some products will have specific uses, while others may treat a range of problems. In keeping with both the historic medical uses of cannabis and the new scientific understanding of how cannabinoids work, Dynamic's cannabinoid pharmaceuticals will be targeting a wide-variety of serious needs such as:

    1. Neuro-muscular disorders, such as MS.
    2. Neuropathic pain, related to spinal cord injuries, as well as
       conditions such as AIDS/HIV and the side-effects of its medications,
       etc. for which opiates are not very effective.
    3. Chronic pain, to reduce or eliminate patients' dependence on opiates.
    4. Respiratory inflammation, related to both infections such as influenza
       and to autoimmune diseases such as asthma.
    5. Cancer, including pain management, control of nausea resulting from
       chemotherapy as well as loss of appetite related to the disease itself.
    6. Also control of cancer in conditions such as Pheochromocytoma.
    7. Digestive illnesses, such as gastroesophageal reflux disease (GERDS),
       Crohn's Disease and irritable bowel syndrome.
    8. Dermatological infections, such as MRSA (flesh eating disease).
    9. Sleep disorders.

President & CEO, Richard Cowan, states, "We are certainly pleased at the speed in which our business model is rolling out. The potential market size for some of these products is obviously very large. When multiplied by the various categories and compounded by multiple country rollouts, we are certainly undertaking
'/>"/>

SOURCE Dynamic Alert Limited
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. CardioDynamics Provides 2007 Shareholder Meeting Update
2. GenVault Partnership with Genome Quebec Brings $3.3 Million Sale of Dynamic Archive Product
3. CardioDynamics Receives FDA 510(k) Clearance for Innovative Clinical Parameters and Electronic Medical Record Compatibility
4. CardioDynamics Ranked in Deloittes Technology Fast 50 Program for San Diego
5. Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer
6. Arryx Launches HOTkit(TM) Complete for Dynamic, Scientific Manipulation of Microscopic Elements
7. CardioDynamics BioZ(R) ICG Technology Featured in American College of Cardiology (ACC) Audio Series
8. Bioscience Company Chooses Microsoft Dynamics AX to Improve Support for Compliance With Industry Rules
9. U.S. Army Awards General Dynamics Contract for Biological Detection System Production and Support
10. CardioDynamics Receives Nasdaq Letter of Non-Compliance With Minimum Bid Price Requirement
11. CardioDynamics Shareholders Approve One-for-Seven Reverse Split of Companys Common Stock and Trading in Post-split Shares Begins May 9, 2008
Post Your Comments:
*Name:
*Comment:
*Email: